Integrating gene and protein expression reveals perturbed functional networks in Alzheimer's disease

S Canchi, B Raao, D Masliah, SB Rosenthal, R Sasik… - Cell reports, 2019 - cell.com
Asymptomatic and symptomatic Alzheimer's disease (AD) subjects may present with
equivalent neuropathological burdens but have significantly different antemortem cognitive …

[HTML][HTML] A multi-network approach identifies protein-specific co-expression in asymptomatic and symptomatic Alzheimer's disease

NT Seyfried, EB Dammer, V Swarup, D Nandakumar… - Cell systems, 2017 - cell.com
Here, we report proteomic analyses of 129 human cortical tissues to define changes
associated with the asymptomatic and symptomatic stages of Alzheimer's disease (AD) …

[HTML][HTML] Hippocampal transcriptome profiling combined with protein-protein interaction analysis elucidates Alzheimer's disease pathways and genes

JGJ Van Rooij, LHH Meeter, S Melhem, DAT Nijholt… - Neurobiology of …, 2019 - Elsevier
Abstract Knowledge about the molecular mechanisms driving Alzheimer's disease (AD) is
still limited. To learn more about AD biology, we performed whole transcriptome sequencing …

Cell type-specific potential pathogenic genes and functional pathways in Alzheimer's Disease

XL Wang, L Li - BMC neurology, 2021 - Springer
Background Alzheimer's disease (AD) is a pervasive age-related and highly heritable
neurodegenerative disorder but has no effective therapy. The complex cellular …

Large-scale deep multi-layer analysis of Alzheimer's disease brain reveals strong proteomic disease-related changes not observed at the RNA level

ECB Johnson, EK Carter, EB Dammer, DM Duong… - Nature …, 2022 - nature.com
The biological processes that are disrupted in the Alzheimer's disease (AD) brain remain
incompletely understood. In this study, we analyzed the proteomes of more than 1,000 brain …

Molecular subtyping of Alzheimer's disease using RNA sequencing data reveals novel mechanisms and targets

RA Neff, M Wang, S Vatansever, L Guo, C Ming… - Science …, 2021 - science.org
Alzheimer's disease (AD), the most common form of dementia, is recognized as a
heterogeneous disease with diverse pathophysiologic mechanisms. In this study, we …

Integrative genomics approach identifies conserved transcriptomic networks in Alzheimer's disease

S Morabito, E Miyoshi, N Michael… - Human molecular …, 2020 - academic.oup.com
Alzheimer's disease (AD) is a devastating neurological disorder characterized by changes in
cell-type proportions and consequently marked alterations of the transcriptome. Here we use …

A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging

JA Miller, MC Oldham, DH Geschwind - Journal of neuroscience, 2008 - Soc Neuroscience
Alzheimer's disease (AD) is a debilitating neurodegenerative disorder affecting millions of
elderly individuals worldwide. Advances in the genetics of AD have led to new levels of …

[HTML][HTML] Multi-transcriptomic analysis points to early organelle dysfunction in human astrocytes in Alzheimer's disease

E Galea, LD Weinstock, R Larramona-Arcas… - Neurobiology of …, 2022 - Elsevier
The phenotypic transformation of astrocytes in Alzheimer's disease (AD) is still not well
understood. Recent analyses based on single-nucleus RNA sequencing of postmortem …

Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease

M Wang, P Roussos, A McKenzie, X Zhou, Y Kajiwara… - Genome medicine, 2016 - Springer
Background Alzheimer's disease (AD) is the most common form of dementia, characterized
by progressive cognitive impairment and neurodegeneration. However, despite extensive …